Enfiera 500mg Injection
In stock
Description
Enfiera 500mg Injection is a targeted monoclonal antibody (Rituximab) that treats specific cancers and severe autoimmune diseases by depleting overactive or malignant B-cells. It is primarily used in oncology and rheumatology to inhibit disease progression and manage inflammation.
Specifications
| Active Ingredient | Rituximab |
|---|---|
| Strength | 500 mg |
| Dosage Form | Intravenous (IV) Injection / Infusion (50ml vial) |
| Therapeutic Area | Oncology (Blood Cancers), Immunology, Rheumatology |
| Shelf Life | 36 months |
| Drug Class | Anti-CD20 Monoclonal Antibody |
